Clik here to view.
Medtronic sponsors sculpture outside Vikings stadium
Medtronic (NYSE:MDT) said today it is contributing a contemporary art sculpture to be placed in Medtronic Plaza outside the Minnesota Vikings’ U.S. Bank Stadium. The 25 foot tall, 107 foot long statue,...
View ArticleClik here to view.
Hologic launches new MyoSure Reach device
Hologic (NSDQ:HOLX) said today it is launching the MyoSure Reach device, designed to manage hard-to-Reach uterine pathology to access the upper third of the uterine cavity. The addition is an expansion...
View ArticleClik here to view.
NeuSpera raises $8m for injectable neuromod devices
NeuSpera Medical said yesterday it raised $8 million in a new round of equity financing to support its injectable neuromodulation devices. NeuSpera, formerly known as Vivonda Medical, is developing...
View ArticleClik here to view.
Biotronik launches Orsiro drug-eluting stent trial
Biotronik said today it enrolled the 1st patient in its BiostemI trial looking to compare the safety and efficacy of its Orsiro hybrid drug-eluting stent with Abbott‘s (NYSE:ABT) Xience Xpedition in...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 11, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Adhesys inks licensing deal for surgical adhesive
German surgical adhesive company Adhesys Medical said today it inked a supply agreement deal with the Grünenthal Group which gives the group exclusive distribution rights for Ahesys’ topical skin...
View ArticleClik here to view.
Medtronic patent exec Ruschke nominated to lead PTAB | Personnel Moves May...
Medtronic patent exec Ruschke nominated to lead PTAB Former Medtronic (NYSE:MDT) patent executive David Ruschke has been appointed as the new Chief Judge for the Patent Trial and Appeal Board. Rushke...
View ArticleClik here to view.
InVivo adds 20th clinical site to Inspire study
InVivo Therapeutics (NSDQ:NVIV) said today it added Philadelphia’s Hospital of the University of Pennsylvania as a site in the Inspire study of its neuro-spinal scaffold, bringing the total number of...
View ArticleClik here to view.
Merging medicine and theater: Training ‘on location’
Pediatric medicine just took a step for the better in Boston’s Longwood Medical Area with a new, expanded pediatric Simulation (SIM) Center — a dedicated space where doctors, nurses and other staff can...
View ArticleClik here to view.
Corvia Medical lands CE Mark for heart shunt
Corvia Medical said today that it landed CE Mark approval in the European Union for its InterAtrial Shunt device for treating a type of heart failure. The IASD is designed to lower blood pressure in...
View ArticleClik here to view.
Cardinal Health’s Cordis gets back in the drug-eluting stent game with...
Cardinal Health (NYSE:CAH) said today that its Cordis subsidiary is getting back into the drug-eluting stent game via an overseas distribution agreement with Biosensors International (PINK:BSNRY). The...
View ArticleClik here to view.
Median Technologies expands U.S. footprint
France’s Median Technologies (EPA:ALMDT) is consolidating and expanding in Massachusetts, with a new Woburn facility set to open next week. The medical imaging software maker and developer said the...
View ArticleClik here to view.
EndoStim raises $25m Series D for neurostim GERD device
Five months after spiking its plans for an initial public offering, EndoStim said today that it raised a $25 million Series D round for the neurostimulation device it’s developing to treat...
View ArticleClik here to view.
Teleflex prices $400m debt offering
Teleflex (NYSE:TFX) yesterday priced $400 million worth of debt that the maker of surgical tools and equipment plans to use for debt refinancing. The offering, of 4.875% senior notes due in 2026, is...
View ArticleClik here to view.
Health advocates pan research funding bills that would streamline FDA approvals
Measures in the U.S. Congress that would link research funding to moves designed to simplify the approval process for medical devices and drugs is reportedly drawing flak from public health advocates,...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for May 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Baxter said to be front-runner in $1.2B race for India’s Gland Pharma
Baxter (NYSE:BAX) is the front-runner in the chase for has emerged as the frontrunner to buy India’s Gland Pharma for as much as $1.2 billion, according to the Economic Times. Hyderabad-based Gland,...
View ArticleClik here to view.
ConforMIS plunges on lowered outlook, search for new CEO
Shares of ConforMIS (NSDQ:CFMS) closed down nearly -8% yesterday and plunged another -40% in after-hours trading, after the medical device company lowered its outlook for the rest of the year and said...
View ArticleClik here to view.
Shareholder sues as Cardiovascular Systems wins extension to settle kickbacks...
A Cardiovascular Systems (NSDQ:CSII) shareholder sued the company in a derivative lawsuit this week, even as the medical device maker won an extension to negotiate a settlement in the very kickbacks...
View ArticleClik here to view.
FDA approves Biofrontera’s drug-device combo for sun-induced skin cancer
Biofrontera (ETR:B8F) shares are up today after the said it won pre-market approval from the FDA for its drug-device combination treatment for a type of sun-induced skin cancer. Leverkusen,...
View Article